Vindeburnol
Code | Size | Price |
---|
TAR-T35056-5mg | 5mg | £1,733.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T35056-50mg | 50mg | £3,428.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T35056-100mg | 100mg | £4,729.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Vindeburnol is a cerebral vasodilator vincamine analog that bears neuroprotective properties.
CAS:
68779-67-9
Formula:
C17H20N2O
Molecular Weight:
268.36
Purity:
0.98
SMILES:
[H][C@@]12CCCN3CCc4c(n([C@H](O)C1)c1ccccc41)[C@]23[H]
References
Mondal P, Argade NP. Correction: Stereoselective synthesis of (-)-desethyleburnamonine, (-)-vindeburnol and (-)-3-epitacamonine: observation of a substrate dependent diastereoselectivity reversal of an aldol reaction. Org Biomol Chem. 2016 Nov 8;14(44):10534. PubMed PMID: 27775144.
Mondal P, Argade NP. Stereoselective synthesis of (-)-desethyleburnamonine, (-)-vindeburnol and (-)-3-epitacamonine: observation of a substrate dependent diastereoselectivity reversal of an aldol reaction. Org Biomol Chem. 2016 Nov 8;14(44):10394-10406. PubMed PMID: 27734054.
Polak PE, Kalinin S, Braun D, Sharp A, Lin SX, Feinstein DL. The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus. J Neurochem. 2012 Apr;121(2):206-16. doi: 10.1111/j.1471-4159.2012.07673.x. Epub 2012 Feb 17. PubMed PMID: 22288774.
Patat A, Le Go A, Foulhoux P. Dose-response relationship of vindeburnol based on spectral analysis of posturographic recordings. Eur J Clin Pharmacol. 1985;29(4):455-9. PubMed PMID: 3912189.